Tempus AI - AI Platform Review & Benchmark 2026

Last reviewed: April 2026

Tempus AI is a leading AI-enabled precision medicine company that has built one of the world's largest libraries of clinical and molecular data.

What is Tempus AI?

Tempus AI is a leading AI-enabled precision medicine company that has built one of the world's largest libraries of clinical and molecular data. By applying AI to genomic sequencing, clinical records, and imaging data, Tempus helps physicians make more personalized treatment decisions for cancer and other diseases. The platform has been used in the care of over 1 in 3 cancer patients in the US.

Who Should Use This

Tempus AI is best suited for oncologists and pathologists, health system administrators, pharmaceutical companies at enterprise organizations. Enterprise pricing with dedicated support and custom deployment.

AI Scanner Score: 9.2/10

Platform Details

Strengths

Weaknesses

Use Cases

Pricing Plans

Key integrations: Epic, Cerner/Oracle Health, Flatiron Health, NVIDIA Clara, AWS

Official website: Tempus AI

Top Alternatives to Tempus AI

Compare Tempus AI with other platforms

Explore all Biotech AI tools

Tempus AI Overview

The platform is designed to address the specific challenges faced by Biotech organizations. Key users include Oncologists and pathologists, Health system administrators, Pharmaceutical companies who rely on the platform for genomic tumor profiling and mutation analysis, ai-powered clinical trial matching, pathology image analysis and diagnosis support. Deployment options include Cloud, allowing organizations to choose the infrastructure setup that best fits their security and compliance requirements. The platform is scaled for Enterprise organizations seeking to modernize their genomics & precision medicine capabilities. In the rapidly evolving Biotech landscape, Tempus AI stands out by combining genomics & precision medicine capabilities with industry-specific features that address the unique challenges of genomic tumor profiling and mutation analysis, ai-powered clinical trial matching, pathology image analysis and diagnosis support. The platform enables Oncologists and pathologists and Health system administrators to transition from manual, error-prone processes to automated, data-driven workflows that deliver consistent results at scale.

How to Evaluate Tempus AI

Before adopting Tempus AI or any Genomics & Precision Medicine solution for your biotech workflows, it is important to assess how the platform fits your specific requirements. Start by mapping your highest-priority pain points — whether that is reducing manual tasks, improving data accuracy, scaling customer interactions, or accelerating time to insight. Tempus AI positions itself as a Genomics & Precision Medicine solution, having been in the market since 2015, so evaluate whether its feature set directly addresses those pain points rather than relying on feature-list comparisons alone.

Request a live demo or proof-of-concept trial before committing to an annual contract. During the trial, measure concrete outcomes: task completion time, error rates, user adoption speed, and integration friction with your existing stack (Tempus AI integrates with Epic, Cerner/Oracle Health, Flatiron Health, NVIDIA Clara). Compare these metrics against at least two alternative vendors in the Genomics & Precision Medicine space to establish a meaningful benchmark. Tempus AI uses a Genomic profiling tests: $3,000-$5,000 per test (often covered by insurance/Medicare). Enterprise platform subscriptions for health systems and pharma companies are custom-priced. pricing model — make sure you understand the total cost of ownership including implementation, training, and any per-seat or usage-based fees.

Deployment options include Cloud, so confirm which model meets your IT and compliance requirements. Tempus AI holds HIPAA, CLIA certified, CAP accredited, GDPR, SOC 2 certifications, which may be critical for regulated biotech use cases. Also ask about the vendor's SLA for uptime, support response times, and the data export process should you decide to switch providers in the future.

Frequently Asked Questions

What is Tempus AI used for?

Tempus AI is a Genomics & Precision Medicine platform designed for biotech organizations. Tempus AI is a leading AI-enabled precision medicine company that has built one of the world's largest libraries of clinical and molecular data.

How does Tempus AI score on AI Scanner?

Tempus AI scores 9.2/10 on AI Scanner's independent evaluation. The score reflects performance (30%), usability (25%), pricing value (25%), and versatility (20%). Scores are updated monthly based on product changes, user feedback, and competitive benchmarking across Genomics & Precision Medicine tools. Read our full scoring methodology.

What are the best alternatives to Tempus AI?

The top alternative to Tempus AI on AI Scanner is Guardant Health with a score of 9.3/10. Other alternatives include Foundation Medicine, Metabolon, Seer Bio. Compare all alternatives.

Is Tempus AI suitable for Enterprise teams?

Tempus AI is designed for enterprise organizations. Its Genomic profiling tests: $3,000-$5,000 per test (often covered by insurance/Medicare). Enterprise platform subscriptions for health systems and pharma companies are custom-priced. pricing model scales with team size and usage requirements. We recommend running a pilot with your actual workflows before committing to a full deployment.

How much does Tempus AI cost?

Tempus AI uses a Genomic profiling tests: $3,000-$5,000 per test (often covered by insurance/Medicare). Enterprise platform subscriptions for health systems and pharma companies are custom-priced. pricing model. For the most accurate pricing, request a custom quote directly from the vendor. Pricing may vary based on deployment scale, feature tier, and contract length. Always factor in implementation and training costs when comparing total cost of ownership against competitors.

How We Score: AI Scanner evaluates platforms across four dimensions - Performance (30%), Usability (25%), Pricing Value (25%), and Versatility (20%). Scores are updated monthly. Read our full methodology.